» Articles » PMID: 12461054

Detection of Liver Kidney Microsomal Type 1 Antibody Using Molecularly Based Immunoassays

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2002 Dec 4
PMID 12461054
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To assess the diagnostic value of two commercial molecularly based immunoassays detecting liver kidney microsomal type 1 antibody (LKM1).

Methods: The performance of Varelisa and LKM1 enzyme linked immunosorbent assay (ELISA) was compared with immunofluorescence, and two validated research techniques-an in house ELISA and a radioligand assay measuring antibodies to P4502D6. Thirty serum samples from three patients with autoimmune hepatitis type 2 covering immunofluorescence titres of 1/10 to 1/10 240 and 55 LKM1 negative controls were tested.

Results: All 30 sera that were LKM1 positive by immunofluorescence were positive by the in house ELISA, the radioligand assay, and LKM1-ELISA, and 29 were also positive by Varelisa. None of the 55 sera negative for LKM1 by immunofluorescence was positive by the in house ELISA and radioligand assay, but one was positive by Varelisa and 14 were positive using the LKM1-ELISA. Agreement between immunofluorescence, the in house ELISA, the radioligand assay, and Varelisa was high (kappa > 0.8), and agreement between immunofluorescence and LKM1-ELISA was moderate (kappa = 0.63).

Conclusion: The assay kit marketed as Varelisa allows accurate detection of LKM1.

Citing Articles

Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies.

Campos-Murguia A, Henjes N, Loges S, Wedemeyer H, Jaeckel E, Taubert R Sci Rep. 2023; 13(1):10038.

PMID: 37340049 PMC: 10282044. DOI: 10.1038/s41598-023-37095-z.


Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.

Sebode M, Weiler-Normann C, Liwinski T, Schramm C Front Immunol. 2018; 9:609.

PMID: 29636752 PMC: 5880919. DOI: 10.3389/fimmu.2018.00609.


Antihistone Autoantibodies in Dobermans With Hepatitis.

Dyggve H, Meri S, Spillmann T, Jarva H, Speeti M J Vet Intern Med. 2017; 31(6):1717-1723.

PMID: 28963850 PMC: 5697184. DOI: 10.1111/jvim.14838.


Autoimmune liver serology: current diagnostic and clinical challenges.

Bogdanos D, Invernizzi P, Mackay I, Vergani D World J Gastroenterol. 2008; 14(21):3374-87.

PMID: 18528935 PMC: 2716592. DOI: 10.3748/wjg.14.3374.

References
1.
Rizzetto M, Swana G, Doniach D . Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973; 15(3):331-44. PMC: 1553909. View

2.
Alvarez F, Berg P, Bianchi F, Bianchi L, Burroughs A, Cancado E . International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31(5):929-38. DOI: 10.1016/s0168-8278(99)80297-9. View

3.
Landis J, Koch G . The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. View

4.
Kenny R, Czaja A, Ludwig J, Dickson E . Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci. 1986; 31(7):705-11. DOI: 10.1007/BF01296447. View

5.
HOMBERG J, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S . Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 1987; 7(6):1333-9. DOI: 10.1002/hep.1840070626. View